Cargando…
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
Despite the progress made in molecular and clinical research, patients with advanced-stage gastric cancer (GC) have a bad prognosis and very low survival rates. Furthermore, it is challenging to find the complex molecular mechanisms that are involved in the development of GC, its progression, and it...
Autores principales: | Aldinucci, Donatella, Casagrande, Naike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983686/ https://www.ncbi.nlm.nih.gov/pubmed/29772686 http://dx.doi.org/10.3390/ijms19051477 |
Ejemplares similares
-
The CCL5/CCR5 Axis in Cancer Progression
por: Aldinucci, Donatella, et al.
Publicado: (2020) -
CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
por: Casagrande, Naike, et al.
Publicado: (2019) -
In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
por: Casagrande, Naike, et al.
Publicado: (2021) -
The Inflammatory Chemokine CCL5 and Cancer Progression
por: Aldinucci, Donatella, et al.
Publicado: (2014) -
Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme
por: Kranjc, Miha Koprivnikar, et al.
Publicado: (2019)